Avondale University

ResearchOnline@Avondale
Education Papers and Journal Articles

School of Education and Science

11-25-2013

Suboptimal Omega-3 Levels in Australian Adolescents
Ross Grant
Australasian Research Institute, ross.grant@sah.org.au

Jade Guest
Australasian Research Institute

Ayse Bilgin
Macquarie University

Margaret J. Morris
University of New South Wales

Manohar Garg
University of Newcastle

See next page for additional authors

Follow this and additional works at: https://research.avondale.edu.au/edu_papers
Part of the Education Commons

Recommended Citation
Grant, R., Guest, J., Bilgin, A., Morris, M., Garg, M. and Pearce, R. (2013). Suboptimal omega-3 levels in
Australian adolescents. International Journal of Child Health and Nutrition, 2(4), 309-315. doi:10.6000/
1929-4247.2013.02.04.4

This Article is brought to you for free and open access by the School of Education and Science at
ResearchOnline@Avondale. It has been accepted for inclusion in Education Papers and Journal Articles by an
authorized administrator of ResearchOnline@Avondale. For more information, please contact
alicia.starr@avondale.edu.au.

Authors
Ross Grant, Jade Guest, Ayse Bilgin, Margaret J. Morris, Manohar Garg, and Robyn Pearce

This article is available at ResearchOnline@Avondale: https://research.avondale.edu.au/edu_papers/45

International Journal of Child Health and Nutrition, 2013, 2, 309-315

309

Suboptimal Omega-3 Levels in Australian Adolescents
Ross Grant1,3,6,*, Jade Guest1, Ayse Bilgin2, Margaret J. Morris3, Manohar Garg4 and
Robyn Pearce5
1

Centre for Lifestyle Medicine and Research, Sydney Adventist Hospital, Australia

2

Department of Statistics, Faculty of Science, Macquarie University, Australia

3

Department of Pharmacology, School of Medical Sciences, UNSW, Australia

4

School of Biomedical Sciences and Pharmacy, University of Newcastle, Australia

5

Faculty of Education, Business and Science, Avondale College of Higher Education, Australia

6

Sydney Medical School, University of Sydney, Australia
Abstract: Objective: To quantitate the omega-3 status in a cohort of Australian adolescents.
Design, Setting and Participants: A cross-sectional descriptive study of 251 apparently healthy adolescents (192 female,
59 male) aged 15-17 years, in year 11, from 10 schools within the Northern Sydney and Central Coast areas of New
South Wales. Participants provided a morning non-fasting blood sample via finger-prick and written answers to specific
demographic and lifestyle questions. Omega-3 index was calculated by adding %EPA and %DHA values in the whole
blood. Equivalent erythrocyte omega-3 index values were obtained by using conversion factors (1.33 for EPA and 2.22
for DHA) from published erythrocyte/whole blood values.
Main Outcome Measures: Quantitation of the individual, and estimation of the group average, blood omega-3 Index.
Results: The blood omega-3 Index for this adolescent cohort ranged from 2.1-22.3 with a mean of 8.3±3.2, and median
of 7.8. On average males had a higher omega-3 Index compared to females (10.5±3.7 vs 7.7±2.6, p<0.001). Fifty three
percent of adolescents tested had an omega-3 Index below the optimum of >8. Three percent had an Index of <4,
placing them in the high risk category for disease.
On average, adolescents from low or medium socioeconomic communities had a significantly lower omega-3 Index
compared to those from higher socioeconomic neighbourhoods (mean difference=1.4, p=0.018). Overall 20% of boys
and 17% of girls reported regularly taking omega-3 supplements. Regular use of omega-3 supplements was associated
with a higher average omega-3 Index (9.8±3.7, n=44 compared to 8.0±3.0, n=203, p=0.001 in those not taking
supplements).
Conclusion: This study indicates that Australian adolescents, even when from advantaged homes, have a high
probability of below optimum omega-3 levels. As reduced omega-3 levels are linked to conditions of public health
concern such as diabetes, asthma and depression, targeted strategies to improve the omega-3 status in the childhood
population may be warranted.

Keywords: Polyunsaturated fatty acids, child, health, brain, depression.
INTRODUCTION
The importance of the essential, dietary derived,
polyunsaturated fatty acids (PUFAs) omega-6 and
omega-3 to human health were first reported by Burr
and Burr in two landmark publications almost 90 years
ago [1,2]. Though some decades elapsed before
PUFAs commanded a reasonable priority in medical
research an escalating body of evidence now indicates
that adequate levels of both omega-6 and omega-3
PUFAs are required to maintain optimum health
throughout life [3].
A western
amounts
of

diet typically supplies substantial
omega-6
through
ingestion
of
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manufactured foods containing oils such as corn,
safflower, grape-seed, sunflower, peanut and soybean.
However this same diet has limited capacity to provide
omega-3 [4], suggesting that ingestion of omega-3
PUFAs may not be optimal in either adult or adolescent
populations.
This is of concern as research now indicates that
sufficient intakes of omega-3 PUFAs is helpful in the
reduction of a wide range of chronic medical conditions
including cardiovascular disease, depression, anxiety,
diabetes, asthma, and rheumatoid arthritis [5-9].
The multiple beneficial effects attributed to omega3s are due to the involvement of this family of PUFAs,
including alpha linolenic acid (ALA), ecosopentanoic
acid (EPA) and docosohexanoic acid (DHA) and their
derivatives (eicosanoids, resolvins and protectins), in a
diverse range of biochemical pathways and cellular
© 2013 Lifescience Global
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functions including metabolism, cell membrane fluidity,
intracellular signaling and gene expression [10].
Through these pathways omega-3s influence cell
growth and tissue repair and help modulate aspects of
inflammation and immunity [11]; functions that are
important both to the developing adolescent and
mature adult.
While a considerable body of data is available on
the omega-3 status of adults, relatively few studies
have measured PUFA levels in the child/adolescent; a
time of considerable physiological development both
systemically and in the central nervous system.
The omega-3 PUFA DHA is the most abundant fatty
acid in the human brain. During adolescence the brain
goes through a critical stage of neural development
[12], where selective synaptic elimination and neural
network
remodelling may
be influenced by
environmental factors. DHA has been shown to
progressively increase in concentration in the brain
from childhood through adolescence, peaking at
around 18 years to adult levels before declining in older
age [13].
While the functional importance of this is still being
elucidated, dietary DHA intake has been associated
with alterations in activity in cortical attention networks
during sustained attention in healthy boys [14]. In
addition, fish consumption (a good source of the
omega-3s DHA and EPA) at age 15 has been
positively correlated with intelligence at 18 [15]. In fact
two separate studies have observed that higher fish
intake is associated with more advanced vocabulary
and higher grades among adolescents [16,17].
Possibly stemming from its relationship to neural
function, omega-3 intake has long been associated
with improvements in mood disorders in adults [18].
While limited data is available for adolescents a recent
study reported that higher intakes of fish, EPA, and
DHA were independently associated with a lower
prevalence of depressive symptoms in male
adolescents [19,20].
Omega-3 intake is also linked mechanistically with
vascular health and therefore risk of both cardio and
cerebro-vascular disease [21]. As omega-3 metabolites
affect inflammatory activity they are thought to reduce
development of pro-atherosclerotic processes. A recent
study by O’Sullivan et al. observed that in boys, higher
omega-3 levels were independently associated with
key cardiovascular risk factors such as total cholesterol
and diastolic blood pressure suggesting that omega-3
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levels may influence cardiovascular health even in the
young [22].
Given the relationship between essential PUFA
levels and multiple health conditions, assessment of an
individual’s omega-3 status seems prudent. Block et al.
showed a significant association between acute
coronary syndrome (ACS) case status and blood cell
EPA + DHA levels, expressed as a percentage of total
membrane fatty acids [23]. This is known as the
omega-3 Index. On the basis of these observations the
cut points for cardiovascular risk were determined to be
<4 = high risk, 4-8 = intermediate risk, >8 = low risk
[23]. Harris, has since argued convincingly for the
omega-3 Index as both a risk marker and risk factor for
cardiovascular disease [24]. More recently work by
Baghi et al. supports an association between low
omega-3 Index (<4) and risk for both cardiovascular
and major depressive disorder (MDD) in adults [25].
While a foundation for disease risk based on
omega-3 status in adults has been developed, a
comparable body of knowledge in relation to omega-3
status and the child/adolescent population is presently
absent.
Two fundamental questions need to be answered:
1)

What is the current status of omega-3 levels in
children/adolescents in various locations around
the world?

2)

Do adult cut-points represent relevant ranges for
the assessment of disease risk in children/
adolescents?

While answers to the second question await further
research, initial characterisation of omega-3 levels in
the younger age groups has begun. A recent study by
O’Sullivan et al. in Western Australia reported a mean
omega-3 Index for 13 to 15 year old children as
4.90±1.04 (range 1.41-8.42), where 15.6% of
adolescents had an Index of <4 putting them in the
high risk category [22]. Complementing the work done
by O’Sullivan et al. the current study reports the
measured omega-3 status from 251, 15 to 17 year old,
adolescents from the east Australian state of New
South Wales.
METHODS
A cross-sectional survey of 251 participants (192
female, 59 male) aged 15 to 17 years was carried out.

Suboptimal Omega-3 Levels in Australian Adolescents

Morphometric Analysis
The height and weight of each participant was
measured using a standard Wedderburn height stick
(mm) and Wedderburn body composition analyser BC420MA. BMI was calculated appropriate to age using
the CDC growth charts developed by the National
Center for Health Statistics in collaboration with the
National Center for Chronic Disease Prevention and
Health Promotion (2000).
Survey Information
Participants provided written responses to questions
detailing their personal demographics and use of
omega-3 supplements. Socioeconomic status (SES)
was determined according to the Socio-Economic
Indexes for Areas (SEIFA) published by the Australian
Bureau of Statistics according to each participant’s
resident postcode [26].
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teflon-lined cap ready for GC analysis. GC analysis
was performed with a 30mx0.25mm (DB-225) fused
carbon-silica column coated with cyanopropylphenyl (J
& W Scientific, Folsom, CA, USA). The injector and
o
dejector ports were set at 250 C and the oven
o
temperature at 170 C for 2 minute, increased by 10
o
o
C/minute to 190 C, held for 1 minute then increased
o
o
by 3 C/min up to 220 C, which was maintained and
run for 30 minutes. The injection volume used was 3 μ
and a split ratio of 10:1. A Hewlett Packard 6890 Series
Gas Chromatograph with Chemstations version
A.04.02 was used in the analysis. The GC was outfitted
with a flame (Palo Alto, CA, USA) ionization detector,
auto-sampler and auto-detector. The fatty acid methyl
ester peaks in the samples were identified by
comparing their retention times with those of a
standard mixture of fatty acid methyl esters. The
coefficient of variation for whole blood fatty acid
analysis is <6%.
Omega-3 Status and Omega-3 Index Comparison

Recruitment and Exclusion Criterion
Participants were recruited from students in year 11
from 10 schools within the Northern Sydney and
Central Coast metropolitan areas as part of a larger
health study. No apparently healthy student was actively
prevented from participating. All participants provided
written informed consent signed by both themselves
and their legal guardian.
Blood Sample Collection
A whole blood sample (~200 μL) was collected from
each participant between 0830 and 1000 hours via
finger-prick in two heparin anticoagulated capillary
o
tubes and stored at 4-8 C for <4 hours before
processing.
Omega-3 Analysis
A comprehensive range of fatty acids were
analyzed by gas chromatography (GC) based on the
methods of Lepage and Roy [27]. Methanol/toluene
(4:1, by volume) of 2 mL was mixed with C19:0 (0.2
mg/mL) and BHT (0.12 g/L), added to the erythrocyte
pellet and vortexed. On vortexing the sample, 200 μL
acetyl chloride was added drop-wise to methylate the
o
fatty acids, followed by heating to 100 C for 1 hour.
Samples were allowed to cool, and the reaction was
stopped by the addition of 5 μL of 6% K2CO3 and
vortexed. The samples were centrifuged at 3000xg at 4
o
C for 10 min to separate the layers. The upper layer
containing toluene and fatty acid methyl esters was
transferred to a 2 mL glass vial, crimp sealed with a

For the purpose of this study the whole blood
omega-3 status is defined as the percentage of the
long chain polyunsaturated fatty acids, ecosopentanoic
acid (EPA) + docosohexanoic acid (DHA) relative to
total fatty acid content in the whole blood.
To facilitate comparison with published data on the
red cell omega-3 Index, the whole blood omega-3
status as determined in this study was converted to the
equivalent omega-3 Index using an average of the
conversion factors published by Bell et al. for EPA
(average of 1.3582 and 1.3186) = 1.3384 and DHA
(2.2121 and 2.2202) = 2.2242 [28].
Statistical Analysis
All statistical analyses were performed using SPSS
for windows version 19.0. The means and standard
deviations of the Omega-3 Index values represent the
estimated values. Levene’s test for equality of
variances showed that the equality of the variances
assumption cannot be rejected for all separate groups
(i.e. gender) comparisons. Two sample t-test is used
for comparing group means and chi square statistics
for comparing categorical variables (i.e. gender versus
disease cut points). Statistical significance is reported
at 0.05, 0.01 and 0.001 levels.
Ethical Approval
This study was conducted in accordance with the
Helsinki declaration. Approval was obtained from the
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Human research Ethics Committee (HREC) of the
Sydney Adventist Hospital (HREC# 06/08).
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No significant correlations were observed between
BMI and Omega 3 Index for either the group as a
whole or male and female subsets.

RESULTS
As shown in Table 1, on average males had a
significant 27% higher omega-3 Index compared to
females (p<0.001). Adolescents from low or medium
socioeconomic communities had a significant 16%
lower average omega-3 level compared to those from
higher socioeconomic neighbourhoods. Adolescents
from homes where English was not the first language
showed an 11% greater omega-3 membrane content.
Although this was statistically significant, the average
difference between the omega-3 indices for the two
groups was only 0.9 (Table 1).

Two hundred and fifty one adolescents from 10
different Sydney upper north shore (90.4%) and
Central Coast (9.6%) high schools participated in this
cross sectional study. The cohort consisted of 24%
males and 76% females aged 15 to 17 years with a
group mean BMI of 22.1 (sd=3.7). For boys the BMI
ranged from 16.8 to 30.5, mean of 22.2 (sd=3.3) and
for girls, 13.1 to 35.6 with a mean of 22.0 (sd=3.8). The
omega-3 Index for the group ranged from 2.1 to 22.3
(Figure 1) with a mean of 8.3±3.2 (Table 1).

As no data is currently available specifying omega-3
levels and risk of pathology in children, the established
cut points for risk of disease in adults is used [23].
Table 2 shows that as a group, 53% of adolescents
in this cohort have below optimum (i.e. <8) omega-3
levels, with 3% represented in the high risk (i.e. <4)
category. Females had on average lower omega-3
levels than males (Table 1) with 62% showing
concentrations below the optimum (i.e. <8) and 4% in
the high risk (<4) category. In comparison only 24% of
male adolescents tested were below the optimum (i.e.
<8) and none were in the high risk (i.e. <4) category.
The association between the gender and Omega 3
Index disease categories was statistically significant
(2=26.9, df=2, p<0.001).

Figure 1: Distribution of whole blood omega-3 levels,
expressed as the omega-3 Index, in a cohort of Australian
adolescents aged15-17 years, (Reference line on the X axis
shows the median = 7.83).

A record of self-reported supplement intake was
also obtained for each participant. Overall 20% of boys
and 17% of girls reported regularly taking omega-3
supplements. Supplement intake was not statistically
biased toward either gender. Adolescents reporting
regular use of omega-3 supplements had a statistically

Table 1:
Omega-3 Index

Omega-3 Index

Mean(sd)

Median

8.3(3.2)

Male

n

p value

7.8

251

--

10.5(3.7)

10.1

59

Female

7.7(2.6)

7.3

192

English

8.1(3.0)

7.7

177

other

9.0(3.4)

8.2

74

High

8.5(3.0)

8.1

219

Low/medium

7.1(3.9)

6.7

32

Demographic
All Adolescents (15-17yrs)
Gender ***

st

<0.001

1 Language*

0.044

SES*

0.018

Statistical significance levels *p<0.05, **p<0.01, ***p<0.001.
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Table 2:
Omega-3 Index
Disease cut-points

% of adolescents represented
in each category

% of each gender represented in each category
Male (n=59)

Female (n=192)

<4 (high risk)

3

0

4

4-8 (moderate risk)

50

24

58

>8 (low risk)

47

76

38

significant higher whole blood omega-3 status
(9.8±3.7, n=44) compared to adolescents not taking
supplements (8.0±3.0, n=203) (p=0.001). The higher
the omega-3 Index the more likely the adolescent was
to be taking a regular omega-3 supplement (Table 3),
although the association between taking supplement
and risk categories was not significant (p=0.074).
Table 3:

Disease cut-points

Omega-3 Index

% of adolescents in each
category taking omega-3
supplements

<4 (high risk)

0

4-8 (moderate risk)

12

>8 (low risk)

25

DISCUSSION
Omega-(n)-3 polyunsaturated fatty acids include the
shorter chain precursor alpha-linolenic acid (ALA) and
the
major
cell
membrane
components
eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), which are particularly rich in neuronal
membranes. These have a wide range of effects, from
immune-modulation and improved vascular function to
synaptic plasticity.
A large body of data from studies in adult
populations provides general endorsement of the
biological benefits of omega-3. However relatively few
studies have quantitatively measured omega-3
incorporation in adolescents.
While dietary estimates have been reported in
children [29], the present investigation is one of only
two studies world-wide that have reported quantitatively
measured omega-3 levels in an adolescent population.
The average omega-3 Index reported for the cohort
of 15 to 17 year old adolescents in the present study
was higher than that recently reported for a population
of West Australian 13 to 15 year olds; 8.3±3.2 vs

4.9±1.0 [22]. While a very significant 53% of
adolescents in the present study were still below the
optimum omega-3 Index of >8, only 3% of this cohort
had an omega-3 Index of <4 placing them in the high
risk category for degenerative disease (Table 2). This
was considerably less than the 15.5% reported for the
West Australian cohort [22]. This discrepancy was
unexpected though likely reflects key differences
between the two groups. Both adolescent groups
represent populations living close to large coastal
Australian cities. However the significant geographical
separation of the two populations, one on the east and
the other the west coast of the continent may be a
factor. In addition the majority (87%) of adolescents in
the current study were from homes categorised as
having high SES while the West Australian cohort were
derived from suburbs categorised as medium SES (i.e.
Subiaco, WA). Our data indicates that children from
higher SES homes have a higher average omega-3
Index (Table 1). This observation is consistent with that
reported by O’Sullivan et al. who observed a correlation
between maternal education, which is linked to SES,
and omega-3 Index [22]. A high proportion (i.e. 29%) of
adolescents within our east coast cohort were also
from migrant families, a demographic that also reported
higher average omega-3 levels (Table 1). Finally the
mean omega-3 Index recorded in our east Australian
cohort is closer to that recently reported for adult
populations 7.0±1.9% [30], 6.1±1.5% [31]. In addition to
the points already mentioned it is possible that the
higher proportion of older students in our cohort,
reflecting a more developed physiology, may also have
contributed to a higher average omega-3 Index.
Unfortunately no data is currently available for
comparison with an international cohort.
Irrespective of the relative difference between the
present adolescent cohort and the previous study, the
high percentage of adolescents presenting with less
than optimal omega-3 Index values may be of some
concern. Adolescence is a time of considerable growth
and organ development both systemically and within
the central nervous system. Omega-3 PUFAs influence
a variety of cell/physiological activities including;

314

International Journal of Child Health and Nutrition, 2013 Vol. 2, No. 4

membrane fluidity, neural plasticity, vascular function
and anti-inflammatory immune signalling. Reduced
omega-3 levels are therefore associated with the
pathophysiology of disorders such as cardiovascular
disease, depression, anxiety, diabetes and asthma [59].
While effects on vascular pathology may not be
clinically obvious in the adolescent, O’Sullivan et al. did
report a reduction in cardiovascular risk factors in
adolescent boys with increasing omega-3 levels [22].
Consistent with a greater prevalence in females,
reduced omega-3 intakes have also been linked to the
rise in adolescent melancholia, particularly among
females [20]. Multiple mechanisms undoubtedly
contribute to the development of depression. However,
as adolescence is a critical stage in the expansion of
neural networks, lower brain omega-3 levels may
negatively influence the neurodevelopment of robust
emotion-associated signalling [32].
Ensuring adequate levels of omega-3 incorporation
in the developing adolescent seems reasonable to
ensure optimum organ growth and development. Both
this study and the West Australian study indicate that
the majority of Australian adolescents are probably not
ingesting sufficient amounts of omega-3 to provide
optimal health [22]. This observation is likely to reflect
the omega-3 status in adolescent populations of other
global locations where western-style nutrition patterns
predominate. However this hypothesis awaits further
quantitative confirmation.
The data presented in this report is consistent with
the proposition that modern urban communities are at
risk of omega-3 deficiency [33]. As food security for
developed nations like Australia has been achieved in
part through the manufacture of edible products with
long shelf lives, most packaged items are low in the
easily oxidisable omega-3 PUFAs. Therefore as most
commonly consumed foods will be low in omega-3 rich
PUFAs, recommendation of a high quality supplement
is arguably the most effective method of correcting this
apparent state of omega-3 fatty acid insufficiency.
LIMITATIONS
Though the significant observations in this study are
statistically valid it is relevant to note that the general
applicability of some findings may be affected by two
factors unique to this cohort. 1) Participants recruited
represent a generally privileged demographic within
Australia with the largest percentage of students from
homes in the high socioeconomic band. However as
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this demographic generally has the education and
financial facility to provide a best-case-healthy
environment for their children, the significant number of
adolescents showing below optimum omega-3 levels
even in this cohort suggests these results may
underestimate the problem in the wider Australian
community. 2) This study cohort also had a higher
percentage of girls than boys. Thus as stated
previously, the observed gender bias needs to be
verified. Finally the clinical relevance of the calculated
omega-3 index remains to be verified for an adolescent
population as these cut points and calculations are
based on research carried out in adults.
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